Faculty

Stephen Schwartz

Professor, Epidemiology

206-685-1799
stevesch@uw.edu

Education

PhD Epidemiology, University of Washington, 1990
MPH Epidemiology, Yale University, 1984

Contact

206-685-1799
stevesch@uw.edu

University of Washington
Box 351619
Department of Epidemiology
Hans Rosling Center for Population Health, 861B
Seattle, WA 98195

Research Areas

Research Interests

Dr. Schwartz primarily studies the etiology and outcomes of cancer. A major objective of his research is to determine the influence of genetic susceptibility, either alone or in combination with lifestyle and environmental risk factors. Current funded research projects include studies focusing on the genetic and non-genetic risk factors for HPV-cancers and testicular germ cell tumors. Other areas of cancer research focus on molecular markers for oral cancer outcomes and the health and well-being of adolescent and young adult cancer survivors. Among his other responsibilities in the field of cancer epidemiology, he serves as Principal Investigator of the Cancer Surveillance System, a population-based cancer registry at the Fred Hutchinson Cancer Research Center.

Recent Publications (PubMed)

Risk factors for severe acute kidney injury after pediatric hematopoietic cell transplantation.
(2023 Apr)
Pediatr Nephrol 38(4): 1365-1372
Bauer A, Carlin K, Schwartz SM, Srikanthan M, Thakar M, Burroughs LM, Smith J, Hingorani S, Menon S
Using ensembles and distillation to optimize the deployment of deep learning models for the classification of electronic cancer pathology reports.
(2022 Oct)
JAMIA Open 5(3): ooac075
De Angeli K, Gao S, Blanchard A, Durbin EB, Wu XC, Stroup A, Doherty J, Schwartz SM, Wiggins C, Coyle L, Penberthy L, Tourassi G, Yoon HJ
Evaluation of cognitive function in the Dog Aging Project: associations with baseline canine characteristics.
(2022 Aug 25)
Sci Rep 12(1): 13316
Yarborough S, Fitzpatrick A, Schwartz SM, Dog Aging Project Consortium
Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk.
(2022 Sep 2)
Cancer Epidemiol Biomarkers Prev 31(9): 1769-1779
Grasso C, Popovic M, Isaevska E, Lazzarato F, Fiano V, Zugna D, Pluta J, Weathers B, D'Andrea K, Almstrup K, Anson-Cartwright L, Bishop DT, Chanock SJ, Chen C, Cortessis VK, Dalgaard MD, Daneshmand S, Ferlin A, Foresta C, Frone MN, Gamulin M, Gietema JA, Greene MH, Grotmol T, Hamilton RJ, Haugen TB, Hauser R, Karlsson R, Kiemeney LA, Lessel D, Lista P, Lothe RA, Loveday C, Meijer C, Nead KT, Nsengimana J, Skotheim RI, Turnbull C, Vaughn DJ, Wiklund F, Zheng T, Zitella A, Schwartz SM, McGlynn KA, Kanetsky PA, Nathanson KL, Richiardi L
Lifetime prevalence of malignant and benign tumours in companion dogs: Cross-sectional analysis of Dog Aging Project baseline survey.
(2022 Dec)
Vet Comp Oncol 20(4): 797-804
Schwartz SM, Urfer SR, White M, Megquier K, Shrager S, Dog Aging Project Consortium, Ruple A
Show complete publication list